LONDON, July 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a partnership with OhioLINK, Ohio's academic library consortium, and SearchOhio, a consortium of Ohio public libraries, to develop a new library resource sharing consortial experience. Erin Francoeur, Executive Director of the Westerville Public Library, which oversees the administration, technical infrastructure and consortial catalog for SearchOhio, said: "We are excit ...

LONDON, July 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2024 before the market opens on Tuesday, August 6, 2024. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. Interested parties may access the live audio broadcast by dialing +1 404-975-4839 or toll- ...

Dynamic, interactive data visualizations reveal comprehensive view of the global research and innovation landscape Emmanuel Thiveaud, Senior Vice President for Research & Analytics, Academia & Government at Clarivate said: "We promote responsible research assessment by considering comprehensive profiles and indicators that capture the broad contributions research makes to society in terms of quality and impact." Key findings in the 2024 G20 scorecard include: Notes to editors: * Mainland China includes data ...

Core Insights - Clarivate Plc launched a report analyzing the first year of the Unitary Patent Court (UPC), highlighting its role in the global patent landscape and its interaction with European national courts and other major patent jurisdictions [1][3] Infringement Cases - The UPC averaged 10 infringement filings per month during its inaugural year, with a 155% increase in decisions published in the second half compared to the first half [2] - German local divisions were responsible for nearly 80% of infringement cases, with Munich leading at 37.7% of all cases filed [2] - Six of the top ten plaintiffs were based in the U.S., and the top ten representative firms handled 71.3% of the total cases [2] Technical Fields - Electrical engineering was the most impacted field, accounting for 39.8% of infringement cases, followed by instruments at 22.6%, mechanical engineering at 16%, and chemistry at 13% [5] - The pharmaceutical sector represented only 3.4% of all UPC infringement cases, while the information and communication technologies (ICT) industry accounted for 38.5% of all patents asserted [5] Revocation Cases - A different trend was noted in revocation cases, where instruments led with 36%, while electrical engineering accounted for only 28% [3]

New report highlights challenges and opportunities in resilient MedTech industry LONDON, July 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of the MedTech Trends to Watch 2024 report, the second installment in a two-part series offering a predictive analysis of emerging trends shaping the MedTech industry. Highlighting both challenges—such as economic uncertainty, regulatory shifts and fragile supply chains—and oppor ...

Core Insights - The report by Clarivate Plc highlights the rapid growth and societal benefits of digital health, emphasizing the integration of various data sources to analyze the evolving landscape of healthcare technology [1][5][6]. Research Impact - The digital health revolution is marked by significant increases in research and patent activity, identifying key global players and emerging companies in the field [5][10]. - The study combines data from the Web of Science and Derwent World Patents Index to provide a comprehensive analysis of digital health, categorized into major fields [5][10]. Growth in Digital Health - There has been a nearly 70-fold increase in academic papers mentioning digital health from 2012 to 2022, driven by advancements in artificial intelligence and analytics [10]. - Patent activity in digital health has surged, with approximately 140,000 patent inventions recorded from 2013 to 2022, indicating strong industry efforts to secure intellectual property [10]. Corporate Dynamics - The patent analysis reveals a diverse mix of organizations involved in digital health, showcasing collaborations between companies like Snap and AstraZeneca, and Nike and Johnson & Johnson [10]. - Mainland China plays a crucial role in AI patenting within digital health, with significant contributions from the Chinese Academy of Sciences and various universities and corporations [10]. Influence of Academic Research - University research is pivotal in driving digital health innovation, with research papers often cited in patents, underscoring their impact on intellectual property advancements [10].

The IP Collaboration Hub enables users to save time and reduce risks in the IP filing and prosecution process by providing a portal for instructors and local agents to collaborate and exchange information, while automatically docketing everything in the IPMS. This portal addresses a critical issue in the IP industry – over-reliance on email for communication – which introduces risk into the process. The Hub automates and standardizes communication management between law firms, corporations and their local a ...

LONDON, June 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2024 update to the Journal Citation Reports™ (JCR™). The reports provide an essential and comprehensive resource of high-quality journals, ranked by field to enable academic institutions, researchers and publishers to gauge the significance of journals in the global research landscape. Changes to journal rankings include the addition of the Emerging Sources Citation I ...

Core Insights - Major pharmaceutical companies are actively seeking partnerships or acquisitions with ADC developers to strengthen their oncology pipelines, as ADCs offer enhanced target specificity and a broader therapeutic index compared to traditional therapies [1][9]. Industry Overview - The ADC landscape is evolving, with over a dozen ADC therapies receiving global approval, and contract development manufacturing organizations (CDMOs) aiding in manufacturing challenges [5]. - The number of ADCs on the global market has increased into double digits over the past five years, indicating their growing significance in modern medicine [9]. Companies to Watch - The report highlights seven innovative companies that are making strides in drug discovery and development, particularly in advancing ADCs for targeted cancer treatments [13]. - Notable companies include: - **Adcendo ApS**: Focuses on ADCs targeting the uPARAP receptor in various cancers, aiming to replace conventional chemotherapy with targeted treatments [14]. - **Araris Biotech AG**: Utilizes proprietary technology for site-specific drug attachment to create more effective and less toxic ADCs [14]. - **GO Therapeutics**: Develops therapies against glycoprotein cancer targets using a platform-based approach [14]. - **Heidelberg Pharma AG**: Employs amanitin-based compounds as ADC payloads, targeting RNA polymerase II for improved treatment options [14]. - **Pheon Therapeutics**: Focuses on novel oncology targets and linker-payload technologies, with a lead program entering clinical stages in 2024 [14]. - **Tallac Therapeutics, Inc.**: Uses next-generation ADC technology with oligonucleotide payloads for targeted immune activation [14]. - **Tubulis**: Aims to deliver targeted anti-cancer agents with stable linkers to minimize offsite toxicities [14]. Methodology - The selection of companies in the report is based on various factors, including medical and business challenges, patient unmet needs, proof of concept, clinical trial positioning, financial health, and intellectual property status [3].

Core Insights - Clarivate Plc has launched Research Horizon Navigator™, an AI-native module within InCites Benchmarking & Analytics™, aimed at identifying emerging research topics for strategic investment and impact [1][3] - The tool utilizes data from the Web of Science Core Collection™ and a novel methodology from the Institute for Scientific Information (ISI)™ to highlight new research trends and interdisciplinary connections [2] Features of Research Horizon Navigator - The module labels each emerging topic with a research theme assigned by generative AI and provides interactive visualizations to show connections between papers, authors, and institutions [2] - It is designed to assist academics, funding agencies, and research organizations in identifying impactful areas for future investments and strategic planning [1][3] Applications and Benefits - Key applications include technology watch, collaboration discovery, funding program management, and research assessment, enabling institutions to monitor research landscapes and identify funding opportunities [5] - Feedback from the research community will guide further enhancements, ensuring the tool remains relevant and effective in identifying emerging research areas [4]